Laura and Isaac Perlmutter Cancer Center at New York University Langone is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Laura and Isaac Perlmutter Cancer Center at New York University Langone has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Advanced Solid Tumors, KRAS p.G12C Mutant Advanced Solid Tumors, Non-small Cell Lung Cancer.
Sponsors: Volastra Therapeutics, Inc., Amgen.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Laura and Isaac Perlmutter Cancer Center at New York University Langone has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Laura and Isaac Perlmutter Cancer Center at New York University Langone has 3 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumors, KRAS p.G12C Mutant Advanced Solid Tumors, Non-small Cell Lung Cancer.
Laura and Isaac Perlmutter Cancer Center at New York University Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.